Prognostic Value of Reduced Heart Rate Reserve during Exercise in Hypertrophic Cardiomyopathy
Quirino Ciampi,Iacopo Olivotto,Jesus Peteiro,Maria Grazia D'Alfonso,Fabio Mori,Luigi Tassetti,Alessandra Milazzo,Lorenzo Monserrat,Xusto Fernandez,Attila Pálinkás,Eszter Dalma Pálinkás,Róbert Sepp,Federica Re,Lauro Cortigiani,Milorad Tesic,Ana Djordjevic-Dikic,Branko Beleslin,Mariangela Losi,Grazia Canciello,Sandro Betocchi,Luis Rocha Lopes,Ines Cruz,Carlos Cotrim,Marco A R Torres,Clarissa C A Bellagamba,Caroline M Van De Heyning,Albert Varga,Gergely Ágoston,Bruno Villari,Valentina Lorenzoni,Clara Carpeggiani,Eugenio Picano,The Stress Echo Study Group On Behalf Of The Italian Society Of Echocardiography And Cardiovascular Imaging Siecvi,Maria D’Alfonso,Eszter Pálinkás,Luis Lopes,Marco Torres,Clarissa Bellagamba,Caroline Van De Heyning,
DOI: https://doi.org/10.3390/jcm10071347
IF: 3.9
2021-03-24
Journal of Clinical Medicine
Abstract:Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (≥50 mmHg) in 281 (30.4%). HRR was 1.90 ± 0.40 (lowest quartile ≤ 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018–1.036, p < 0.001), older age (odds ratio 1.021, 95% CI: 1.009–1.033, p < 0.001), lower exercise tolerance (mets, odds ratio 0.761, 95% CI: 0.708–0.817, p < 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043–2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36–145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116–4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441–7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043–1.085 p < 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037–1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients.
medicine, general & internal